Enwei Pharmaceutical Balance Sheet

Financials in millions CNY. Fiscal year is January - December.

Millions CNY. Fiscal year is Jan - Dec.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Sep '25 Sep 30, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Jan '23 Jan 1, 2023	Jan '22 Jan 1, 2022	Dec '20 Dec 31, 2020
Cash & Equivalents	319.61	370.27	236.12	341.58	64.25	63.02
Trading Asset Securities	205.33	144.72	157.16	236.56	14.4	14.4
Cash & Short-Term Investments	524.94	515	393.28	578.14	78.65	77.42
Cash Growth	5.91%	30.95%	-31.97%	635.07%	1.59%	25.24%
Accounts Receivable	264.6	296.53	265	245.28	192.91	220.59
Other Receivables	4.75	3.69	3.99	4.17	3.98	3.43
Receivables	269.35	300.22	268.98	249.45	196.89	224.02
Inventory	114.49	115.55	107.37	104.65	110.01	78.34
Other Current Assets	28.48	21.27	17.23	25.06	28.21	29.01
Total Current Assets	937.26	952.04	786.86	957.29	413.77	408.79
Property, Plant & Equipment	268.44	246.55	231.12	240	241.77	224.15
Long-Term Investments	-	0.37	0.37	0.35	0.42	0.85
Goodwill	100.55	100.55	100.55	100.55	100.55	100.55
Other Intangible Assets	121.31	133.37	148.04	42.08	47.45	52.26
Long-Term Deferred Tax Assets	5.24	4.64	3.05	1.8	1.74	1.83
Long-Term Deferred Charges	7.76	8.7	10.68	16.83	18.28	19.76
Other Long-Term Assets	56.15	58.3	56.81	47.18	45.11	40.68
Total Assets	1,497	1,505	1,337	1,406	869.09	848.86
Accounts Payable	46.7	49.49	30.94	36.88	33.64	45.95
Accrued Expenses	26.79	132.83	141.69	141.02	128.52	147.3
Current Portion of Long-Term Debt	11.38	10.09	-	-	-	-
Current Portion of Leases	-	1.27	0.88	-	-	-
Current Income Taxes Payable	9.47	6.52	10.21	11.23	8.19	12.69
Current Unearned Revenue	24.48	24.61	14.01	28.15	16.15	13.89
Other Current Liabilities	92.41	13.6	12.04	10.31	12.73	14.35
Total Current Liabilities	211.22	238.42	209.77	227.58	199.22	234.18
Long-Term Debt	180	185	-	-	-	-
Long-Term Leases	0.71	1.52	0.46	-	-	-
Long-Term Unearned Revenue	8.22	9.96	11.92	14.05	15.88	18.06
Long-Term Deferred Tax Liabilities	12.91	11.96	12.17	11.45	11.74	10.1
Total Liabilities	413.06	446.86	234.31	253.08	226.84	262.34
Common Stock	102.89	102.89	70.14	70.14	52.6	52.6
Additional Paid-In Capital	646.3	638.71	671.51	664.63	239.22	239.22
Retained Earnings	393.64	375.25	392.32	418.23	350.43	294.7
Treasury Stock	-59.18	-59.18	-30.78	-	-	-
Total Common Equity	1,084	1,058	1,103	1,153	642.25	586.52
Shareholders' Equity	1,084	1,058	1,103	1,153	642.25	586.52
Total Liabilities & Equity	1,497	1,505	1,337	1,406	869.09	848.86
Total Debt	192.09	197.88	1.34	-	-	-
Net Cash (Debt)	332.85	317.12	391.94	578.14	78.65	77.42
Net Cash Growth	13.33%	-19.09%	-32.21%	635.07%	1.59%	49.41%
Net Cash Per Share	3.33	3.14	3.81	6.85	1.01	1.06
Filing Date Shares Outstanding	101.08	101.08	100.99	103.8	77.85	77.85
Total Common Shares Outstanding	101.08	101.08	102.76	103.8	77.85	77.85
Working Capital	726.04	713.62	577.09	729.7	214.55	174.61
Book Value Per Share	10.72	10.46	10.74	11.11	8.25	7.53
Tangible Book Value	861.79	823.74	854.59	1,010	494.25	433.71
Tangible Book Value Per Share	8.53	8.15	8.32	9.73	6.35	5.57
Buildings	-	289.03	287.63	275.1	274.06	239.09
Machinery	-	301.77	302.77	271.99	263.51	237.07
Construction In Progress	-	40.37	8.82	35.68	23.84	46.75

Source: S&P Global Market Intelligence. Standard template. Financial Sources.